Moreover, it is eye-catching that CARM1-KO T cells exert more effective antitumor effects than wild-type, indicating that CARM1 inhibition enables immunotherapy of resistant tumors by dual effects on tumor cells and T cells, which has great clinical translational value. Here, CARM1 is linked to neoplasm.